Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
$ 7.29
6.11 %
$ 9.29 M
Market Cap
-0.02
P/E
CASH FLOW STATEMENT
-35.8 M
OPERATING CASH FLOW
3.99 K
INVESTING CASH FLOW
21.4 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
RedHill Biopharma Ltd.
| Net Income | 23.9 M |
| Depreciation & Amortization | 1.99 M |
| Capital Expenditures | -11 K |
| Stock-Based Compensation | 1.65 M |
| Change in Working Capital | -15.6 M |
| Others | -98.2 M |
| Free Cash Flow | -35.8 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||
| Net Income | 23.9 | (71.7) | (97.7) | (76.2) | (42.3) | (38.8) | (45.5) | (29.4) | (21.1) | (10.7) | (10.6) | (10.3) | (15.5) | (2.5) |
| Depreciation & Amortization | 2.0 | 8.2 | 18.1 | 8.7 | 1.2 | 90 K | 81 K | 44 K | 36 K | 27 K | 24 K | 24 K | 15 K | 0 |
| Deferred Income Tax | 0 | 0 | 0.1 | 0.2 | 0 | 0.1 | (5.1) | (1.3) | (0.6) | 8 K | 64 K | 73 K | (0.6) | 0 |
| Stock Based Compensation | 1.6 | 5.7 | 10.2 | 4.2 | 3.0 | 2.7 | 2.2 | 1.7 | 1.4 | 1.8 | 1.3 | 1.6 | 2.9 | 80 K |
| Other Operating Activities | (47.8) | 20.6 | 5.4 | 6.0 | (0.3) | 35 K | (0.1) | 94 K | 69 K | 50 K | 70 K | 1.5 | 8.1 | 0.9 |
| Change in Working Capital | (15.6) | 8.0 | (1.2) | 8.4 | (2.3) | 1.4 | 3.7 | 0.6 | 2.6 | (3.4) | 1.0 | 0.5 | 0.4 | 21 K |
| Cash From Operations | (35.8) | (29.2) | (65.0) | (48.6) | (40.7) | (34.5) | (44.8) | (28.3) | (17.8) | (12.2) | (8.4) | (6.8) | (4.7) | (1.6) |
| INVESTING CASH FLOW | ||||||||||||||
| Capital Expenditures | 11 K | (0.2) | (0.1) | (53.8) | (0.2) | 58 K | (1.2) | (0.1) | (1.6) | (1.1) | (0.2) | (0.1) | (0.2) | (1.1) |
| Other Items | 15 K | 8.5 | (8.0) | 18.1 | 5.4 | 5.4 | (17.4) | 24.6 | (19.6) | (16.8) | 1.4 | 3.1 | (4.6) | 92 K |
| Cash From Investing Activities | 3.99 K | 8.3 | (8.1) | (35.6) | 5.2 | 5.4 | (18.6) | 24.5 | (21.2) | (17.9) | 1.1 | 3.0 | (4.8) | (1.0) |
| FINANCING CASH FLOW | ||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | (1.5) | (1.7) | 76.5 | (0.8) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.1 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 7.4 | (10.9) | (3.4) | (15.9) | 5 K | (0.1) | 3.4 | 0.3 | 0.1 | 5.0 | 2.2 | 0.3 | 1.2 | 0 |
| Cash From Financing Activities | 21.4 | 11.5 | 73.5 | 84.4 | 35.5 | 41.8 | 25.7 | 36.0 | 54.8 | 24.4 | 2.3 | 6.5 | 13.8 | 11.1 |
| CHANGE IN CASH | ||||||||||||||
| Net Change In Cash | (14.4) | (9.5) | 0.2 | 0.3 | 18 K | 12.6 | (37.3) | 32.3 | 15.6 | (6.0) | (5.0) | 2.7 | 5.0 | 8.5 |
| FREE CASH FLOW | ||||||||||||||
| Free Cash Flow | (35.8) | (29.4) | (65.2) | (102.4) | (41.0) | (34.5) | (46.0) | (28.4) | (19.5) | (13.3) | (8.7) | (6.9) | (4.9) | (2.7) |